Register Now for 2012 OVALS Conference
UC faculty, staff and students with an interest in commercialization of new life sciences technologies, collaboration opportunities and creating economic impact should plan to attend the 2012 Ohio Valley Affiliates for Life Sciences (OVALS) conference Oct. 1 and 2 in Louisville, Ky.
UC was a founding member of OVALS, which formed in 2002, and is an organizing member of the yearly OVALS conference.
This years conference, titled "Meeting Health Care Challenges Through Technology and Novel Approaches, will cover:
Partnership opportunities for commercialization of medical devices.
Realities of raising capital for startup companies in todays environment.
Startup companies and connecting startups to resources.
Changes in patent law and how they will affect patent process at universities.
Elizabeth Dougherty, director of inventor education, outreach and recognition with the Office of Innovation Development at the U.S. Patent and Trademark Office, will be the presenter on patent changes and policies.
The event will also offer a showcase of exciting university life sciences technologies poised to make a difference and students will have a chance to compete in a technology poster session.
OVALS also encourages attendance by technology transfer professionals, corporate scientists, business development professionals, state and local economic development officials, attorneys, investors, incubators and entrepreneurs.
For more information, details on the poster session or to register for the event, visit www.ovalsgroup.org. Questions should be directed to Dorothy Air, PhD, UC associate vice president for entrepreneurial affairs and technology commercialization, at dorothy.air@uc.edu.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.